Zheng, Y.; Guo, X.; Chen, C.; Chi, L.; Guo, Z.; Liang, J.; Wei, L.; Chen, X.; Ye, X.; He, J.
Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database. Pharmaceuticals 2023, 16, 98.
https://doi.org/10.3390/ph16010098
AMA Style
Zheng Y, Guo X, Chen C, Chi L, Guo Z, Liang J, Wei L, Chen X, Ye X, He J.
Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database. Pharmaceuticals. 2023; 16(1):98.
https://doi.org/10.3390/ph16010098
Chicago/Turabian Style
Zheng, Yi, Xiaojing Guo, Chenxin Chen, Lijie Chi, Zhijian Guo, Jizhou Liang, Lianhui Wei, Xiao Chen, Xiaofei Ye, and Jia He.
2023. "Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database" Pharmaceuticals 16, no. 1: 98.
https://doi.org/10.3390/ph16010098
APA Style
Zheng, Y., Guo, X., Chen, C., Chi, L., Guo, Z., Liang, J., Wei, L., Chen, X., Ye, X., & He, J.
(2023). Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database. Pharmaceuticals, 16(1), 98.
https://doi.org/10.3390/ph16010098